Carvolix Reports Successful Postmarketing Results for TAVIPILOT AI Software
Carvolix announced the completion of its SAITO postmarketing clinical program evaluating the TAVIPILOT software used during Transcatheter Aortic Valve Implantation procedures. The program included three studies involving 30 patients across France and Australia.
The company reported a 100 percent procedural success rate and high clinician satisfaction with the software. TAVIPILOT assists medical teams in precise positioning of heart valves during implantation and has received clearance for commercial use in the United States.
The positive results from the SAITO program support broader clinical adoption of TAVIPILOT as a guidance tool for valve placement. Carvolix also published its 2025 Universal Registration Document and confirmed an extension of its cash runway through additional funding.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Caristo Diagnostics Presents AI Heart CT Data at ESC Congress 2026
Medtronic Invests Up to $80 Million in Pi-Cardia
Medibyt Gets FDA Clearance for CPETWise Cardiopulmonary Test Software
Rhythm AI Study Reports 90% Freedom From Atrial Fibrillation
Ivalua Named a Leader in IDC Direct Spend Assessment
Daily AI Brief: the AI news that matters, in your inbox.